Focus: Adagio Medical is a medical device biotechnology company specializing in continuous lesion ablation systems for cardiac arrhythmias, based in Laguna Hills, California. The company focuses on cryoablation and pulsed field ablation technologies for atrial fibrillation and ventricular tachycardia.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Stable — net +2 jobs in 30d
3 added, 1 removed. Backfill posture.
Adagio Medical is an early-stage device biotech with promising cardiac ablation IP, but limited hiring, uncertain funding runway, and early clinical validation make it a speculative career move best suited for risk-tolerant candidates seeking deep technical involvement.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Adagio Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Adagio Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles